Company news

NovoCure Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Novocure Announces Recipients of 3rd Annual AACR-Novocure Grants for Tumor Treating Fields Research Program

July 14, 2021

Novocure to Report Second Quarter 2021 Financial Results

July 7, 2021

Novocure Presents Final Safety and Efficacy Results from its Phase 2 Pilot HEPANOVA Trial in Liver Cancer

June 30, 2021

Novocure Initiates Usability Study for Flexible Torso Array

June 15, 2021

Novocure Announces Clinical Trial Collaboration with GT Medical Technologies to Evaluate Tumor Treating Fields Together with GammaTile® Therapy in Recurrent Glioblastoma

May 24, 2021

Novocure Announces FDA Approval of IDE Supplement for Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in Non-Small Cell Lung Cancer

May 17, 2021

Novocure Reports First Quarter 2021 Financial Results and Provides Company Update

April 28, 2021

Novocure Announces FDA IDE Approval and Steering Committee for KEYNOTE-B36 Trial Evaluating Tumor Treating Fields Together with Pembrolizumab in Non-Small Cell Lung Cancer

April 21, 2021

Zai Lab Partner Novocure Announces Update on Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in Non-Small Cell Lung Cancer

April 12, 2021

Novocure Announces Update on Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in Non-Small Cell Lung Cancer

April 12, 2021

Novocure Announces 26 Presentations at American Association for Cancer Research (AACR) Annual Meeting 2021 Suggesting Broad Applicability of Tumor Treating Fields

April 8, 2021

Novocure to Report First Quarter 2021 Financial Results

March 31, 2021

Novocure Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Company Update

February 24, 2021

Novocure Announces Addition to Its Board of Directors

February 7, 2021

Novocure Announces Fourth Quarter and Full Year 2020 Preliminary Net Revenues and Provides Company Update

January 10, 2021

Novocure to Participate in the 39th Annual J.P. Morgan Virtual Healthcare Conference

December 22, 2020

Novocure Announces National Reimbursement in Switzerland for Optune® in Combination With Temozolomide for the Treatment of Newly Diagnosed Glioblastoma

December 13, 2020

First Patient Enrolled in Novocure’s Global Phase 3 TRIDENT Trial of Optune® Concurrent with Radiation Therapy in Newly Diagnosed Glioblastoma

December 9, 2020

Novocure to Participate in the Evercore ISI 2020 Virtual HealthCONx Conference

November 24, 2020

Novocure Announces 43 Presentations on Tumor Treating Fields at Society for Neuro-Oncology 2020 Virtual Annual Meeting

November 18, 2020

Novocure Receives CE Mark for NovoTTF-100L™ System

November 10, 2020

Novocure Announces Agenda for Virtual Research and Development Day

November 9, 2020

Novocure Announces Closing of $150 Million Revolving Credit Facility with a Syndicate of Relationship Banks

November 8, 2020

Novocure Announces Closing of $575 Million 0% Convertible Senior Notes Private Placement

November 4, 2020

Novocure Prices $500 Million 0% Convertible Senior Notes Private Placement

November 1, 2020

Novocure Announces Proposed Private Placement of $500 Million of Convertible Senior Notes

November 1, 2020

Novocure Reports Third Quarter 2020 Financial Results and Provides Company Update

October 28, 2020

Novocure Announces Strategic Alliance with NYU Grossman School of Medicine for Preclinical and Clinical Research

October 28, 2020

Novocure to Report Third Quarter 2020 Financial Results

October 1, 2020

Novocure to Host Virtual Research & Development Day

September 28, 2020

Novocure Honors Mesothelioma Day with Activities to Raise Awareness of Mesothelioma and Support the Community

September 24, 2020

Novocure to Participate in the 2020 Wells Fargo Virtual Healthcare Conference

September 3, 2020

Novocure Announces Expansion of Its Executive Leadership Team

August 12, 2020

Novocure Reports Second Quarter 2020 Financial Results and Provides Company Update

July 29, 2020

Novocure Announces Recipients of 2nd Annual AACR-Novocure Grants for Tumor Treating Fields Research Program

July 27, 2020

First Patient Enrolled in Novocure’s EF-33 Phase 2 Pilot Trial of Tumor Treating Fields Delivered Utilizing High-Intensity Transducer Arrays

July 21, 2020

Novocure Announces Clinical Trial Collaboration with MSD to Evaluate Tumor Treating Fields Together with KEYTRUDA® (pembrolizumab) in Non-Small Cell Lung Cancer

July 14, 2020

Novocure Announces Over 100 Physicians in the U.S. Now Certified to Prescribe Optune Lua™

July 7, 2020

Novocure Enrolls Last Patient in HEPANOVA Trial Testing Tumor Treating Fields in Combination with Sorafenib in Advanced Liver Cancer

July 6, 2020

← Newer news releases

Calls

The 5 newest of 25 calls. Every call is listed under its year.

Decks

The 5 newest of 25 decks. Every deck is listed under its year.